{"id":"W4238740123","doi":"10.4161/mabs.2.2.11271","title":"Certolizumab Pegol","year":2010,"lang":"it","type":"review","venue":"mAbs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Certolizumab pegol; Medicine; Rheumatoid arthritis; Monoclonal antibody; Infliximab; Arthritis; Internal medicine; Adalimumab; Tumor necrosis factor alpha; Immunology; Antibody","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003912036,0.0007287664,0.0008959707,0.001412261,0.0001958599,0.000846552,0.0005984822,0.001148404,0.01124287],"category_scores_gemma":[0.0006854045,0.0001992806,0.0005728585,0.0009460809,0.0002350887,0.0006433171,0.0006084954,0.001197472,0.00764836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004924301,"about_ca_system_score_gemma":0.0008250641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001354992,"about_ca_topic_score_gemma":0.001295043,"domain_scores_codex":[0.9997714,0.00004383233,0.00003075748,0.0000404045,0.0000847012,0.0000288376],"domain_scores_gemma":[0.9998477,0.00004853749,0.00004557419,0.00000630316,0.00003390804,0.00001804562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001775799,0.00005590007,0.000115809,0.01024153,0.00009380705,0.0001542111,0.00002403269,0.0001548862,0.002631825,0.001180415,0.04357413,0.9415959],"study_design_scores_gemma":[0.0001406899,0.0001113638,0.000525247,0.002075244,0.0001223498,0.001324787,0.00001549108,0.00004577882,0.001196211,0.0005146672,0.9939185,0.000009625778],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004800826,0.992081,0.0004102652,0.0004970808,0.0004191692,0.00004406852,0.0001264594,0.00004938076,0.005892398],"genre_scores_gemma":[0.006826256,0.9842201,0.0006572115,0.001054371,0.0003898162,0.00005752138,0.0004449236,0.000008005234,0.006341888],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01124287,"threshold_uncertainty_score":0.03761113,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0343626504013133,"score_gpt":0.3351339835106432,"score_spread":0.3007713331093299,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}